{"id":"NCT00194077","sponsor":"University Hospitals Cleveland Medical Center","briefTitle":"Study of Aripiprazole (Abilify) in Children With Symptoms of Mania","officialTitle":"Aripiprazole in Children With Symptoms of Mania","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-08","primaryCompletion":"2011-01","completion":"2011-01","firstPosted":"2005-09-19","resultsPosted":"2013-12-05","lastUpdate":"2015-01-07"},"enrollment":60,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Bipolar Disorder"],"interventions":[{"type":"DRUG","name":"Aripiprazole","otherNames":["Abilify"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Aripiprazole","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to look at the safety and effectiveness of aripiprazole (abilify) in children with bipolar disorder and to examine whether or not patients that respond to initial mood stabilization benefit from continued pharmacotherapy.","primaryOutcome":{"measure":"Time in Weeks to Discontinuation","timeFrame":"up to 72 weeks","effectByArm":[{"arm":"Aripiprazole","deltaMin":25.93,"sd":null},{"arm":"Placebo","deltaMin":3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":12},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["22152402","21823912"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":30},"commonTop":[]}}